Evidence map›Paper›PMID 35214170›Full record

ReviewPharmaceutics2022

The Transdermal Delivery of Therapeutic Cannabinoids.

Haleh Mahmoudinoodezh, Srinivasa Reddy Telukutla, Sukhvir Kaur Bhangu, Ava Bachari, Francesca Cavalieri, Nitin Mantri

Abstract readReview
In one paragraph

Review in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Cannabidiol: Pharmaceutical formulations and biomedical applications.Iranian journal of basic medical sciences · 2026
    Review
  7. The Current State of Unapproved Cannabidiol Product Use in Children.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. The Use of Compounds Derived fromInternational journal of molecular sciences · 2024
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Haleh MahmoudinoodezhThe Pangenomics Lab, School of Science, RMIT University, Bundoora, VIC 3083, Australia.
Srinivasa Reddy TelukutlaThe Pangenomics Lab, School of Science, RMIT University, Bundoora, VIC 3083, Australia.ORCID 0000-0002-2806-4300
Sukhvir Kaur BhanguSchool of Science, RMIT University, Melbourne, VIC 3000, Australia.
Ava BachariThe Pangenomics Lab, School of Science, RMIT University, Bundoora, VIC 3083, Australia.ORCID 0000-0002-9864-2794
Francesca CavalieriApplied Chemistry and Environmental Science, RMIT University, Melbourne, VIC 3000, Australia.
Nitin MantriThe Pangenomics Lab, School of Science, RMIT University, Bundoora, VIC 3083, Australia.ORCID 0000-0002-7621-035X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, several studies have indicated an increased interest in the scientific community regarding the application of

Indexed as

bioavailabilityCBDTHCtherapeutic cannabinoidstopicaltransdermal

Identifiers

PMID35214170
PMCPMC8876728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.